Quanterix Corp

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Net loss ($27.0m) ($31.5m) ($40.8m) ($31.5m) ($57.7m) ($96.7m) ($32.3m) ($38.5m) ($107.2m)
Depreciation and amortization expense $482k $1.4m $3.0m $4.3m $4.9m $5.3m $6.4m $6.5m $15.8m $22.3m
Operating lease right-of-use asset amortization $499k $715k $2.0m $1.9m $3.1m
Deferred taxes ($226k) ($290k) ($290k) ($5.9m)
Stock-based compensation expense $2.2m $4.9m $6.4m $10.1m $16.0m $15.4m $16.8m $20.0m $20.7m $19.8m
Payments for employee taxes withheld on stock-based compensation awards $0 ($198k) ($2.6m) ($1.4m)
Impairment $25.6m $1.6m $0 $7.8m
Credit losses on accounts receivable $160k $493k $213k ($301k) $336k $588k $628k
Accounts receivable ($1.7m) ($983k) ($3.4m) ($6.2m) ($6.9m) $5.2m ($6.7m) ($7.7m) $10.6m $9.0m
Inventory ($2.0m) ($1.6m) ($3.4m) ($5.1m) ($8.1m) $5.4m ($5.4m) ($6.7m) $4.0m $5.2m
Accounts payable $1.0m $1.3m $621k $649k $2.4m ($5.4m) $1.2m $723k ($528k) ($5.8m)
Purchases of property and equipment in accounts payable and accruals $74k $78k $7.6m $1.0m $229k $152k $419k $1.2m $121k ($1.4m)
Accrued compensation and benefits, accrued expenses, and other current liabilities $2.0m $1.1m $822k $6.2m $1.1m ($4.0m) $4.3m $1.4m ($7.9m)
Other operating activity $692k ($439k) $150k $55k ($540k)
Prepaid expenses and other current assets ($273k) ($1.8m) $289k ($3.9m) ($393k) ($568k) ($2.4m) ($443k) $3.5m
Net change in other operating assets and liabilities ($2.1m) ($4.9m) ($12.3m)
Net cash used in operating activities ($22.1m)
($28.7m) -29.92%
($26.2m) +8.82%
($23.4m) +10.78%
($47.9m) -105.04%
($48.3m) -0.76%
($18.9m) +60.84%
($35.2m) -86.03%
($77.2m) -119.65%
($81.5m) -5.46%
Purchases of property and equipment ($1.1m) ($1.5m) ($10.8m) ($3.9m) ($13.6m) ($11.7m) ($3.8m) ($3.4m) ($2.6m) ($1.4m)
Accretion of marketable securities $0 ($2.0m) ($6.8m) ($2.1m)
Purchases of marketable debt securities $0 ($175.6m) ($295.6m) ($69.8m)
Proceeds from sales and maturities of marketable securities $0 $31.0m $216.7m $215.8m
Acquisitions, net of cash acquired ($3.8m) ($14.5m) $0 $0 ($93.2m) ($84.2m)
Net cash provided by (used in) investing activities ($1.1m) ($5.5m) ($25.4m) ($626k) ($6.3m) ($11.2m) ($148.4m) ($82.3m) $50.2m $42.7m
Proceeds from common stock issued under stock plans $879k $888k $1.1m $881k $2.9m $3.1m $738k
Common stock issued in exchange for acquisition of Akoya $0 $0 $49.9m
Net cash provided by (used in) financing activities $73.2m
($78k) -100.11%
$116.2m +149070.51%
$96.2m -17.18%
$270.8m +181.39%
$2.3m -99.15%
$2.7m +16.44%
$456k -83.05%
($708k) -255.26%
($1.6m) -121.89%
Cash, cash equivalents, and restricted cash at beginning of period $79.7m $45.4m $110.2m $182.6m $399.0m $341.3m $177.0m $59.3m $33.2m
Net decrease in cash, cash equivalents, and restricted cash $216.6m ($57.2m) ($164.6m) ($117.0m) ($27.7m)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash $118k $158k ($92k) ($538k) $301k ($734k) $1.6m $673k
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Change in fair value of contingent liabilities $0 $0 ($4.5m)
Recognition of off-market liability $0 $0 ($2.7m)
Other non-current assets $267k ($21k) $198k ($2k) ($909k) ($775k) ($1.2m) $252k